GENEVA, Switzerland--(BUSINESS WIRE)--Oct 19, 2023--GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases, announced a collaboration with Verily, an Alphabet precision health technology company, to ...
HORGEN, Switzerland--(BUSINESS WIRE)--Oct 19, 2023--<a ...
ROCHESTER, Minn. & OXFORD, England--(BUSINESS WIRE)--Oct 19, 2023--Mayo Clinic and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology, today unveiled a multi-year joint development collaboration to develop new ...
AACHEN, Germany--(BUSINESS WIRE)--Oct 19, 2023--Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the FDA has approved the PROTEMBO Pivotal IDE Trial (NCT05873816). The trial will recruit between 250-500 randomized patients undergoing ...
KHAN YOUNIS, Gaza Strip (AP) 鈥� Israel said Wednesday that it will allow Egypt to deliver limited humanitarian aid to the Gaza Strip. The first crack in a punishing 10-day siege on the territory came one day after a blast at a hospital killed hundreds and put <a ...
HENDERSON, Nev., Oct. 18, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, welcomed Ambassador Michael M. Adler, U.S. Ambassador to the Kingdom of Belgium for a tour of its purpose-built research, development and manufacturing ...
